Table of Contents Author Guidelines Submit a Manuscript
International Journal of Surgical Oncology
Volume 2015 (2015), Article ID 538948, 7 pages
http://dx.doi.org/10.1155/2015/538948
Research Article

A Single Centre Analysis of Clinical Characteristics and Treatment of Endocrine Pancreatic Tumours

Department of Surgical Gastroenterology and Liver Transplantation, Sir Ganga Ram Hospital, New Delhi 110060, India

Received 2 April 2015; Revised 17 May 2015; Accepted 27 May 2015

Academic Editor: Timothy M. Pawlik

Copyright © 2015 M. T. Adil et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. O. Vortmeyer, S. Huang, I. Lubensky, and Z. Zhuang, “Non-islet origin of pancreatic islet cell tumors,” The Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 4, pp. 1934–1938, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. T. R. Halfdanarson, K. G. Rabe, J. Rubin, and G. M. Petersen, “Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival,” Annals of Oncology, vol. 19, no. 10, pp. 1727–1733, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. R. R. P. Warner, “Enteroendocrine tumors other than carcinoid: a review of clinically significant advances,” Gastroenterology, vol. 128, no. 6, pp. 1668–1684, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. E. K. Nakakura and E. K. Bergsland, “Islet cell carcinoma: neuroendocrine tumors of the pancreas and periampullary region,” Hematology/Oncology Clinics of North America, vol. 21, no. 3, pp. 457–473, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. T. Carriaga and D. E. Henson, “Liver, gallbladder, extrahepatic bile ducts, and pancreas,” Cancer, vol. 75, no. 1, pp. 171–190, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. K. D. Buchanan, C. F. Johnston, M. M. T. O'hare et al., “Neuroendocrine tumors: a European view,” The American Journal of Medicine, vol. 81, no. 6, pp. 14–22, 1986. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Y. Lam and C. Y. Lo, “Pancreatic endocrine tumour: a 22-year clinico-pathological experience with morphological, immunohistochemical observation and a review of the literature,” European Journal of Surgical Oncology, vol. 23, no. 1, pp. 36–42, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Grimelius, G. T. Hultquist, and B. Stenkvist, “Cytological differentiation of asymptomatic pancreatic islet cell tumors in autopsy material,” Virchows Archiv—Abteilung A Pathologische Anatomie, vol. 365, no. 4, pp. 275–288, 1975. View at Google Scholar · View at Scopus
  9. G. Kloppel and P. U. Heitz, “Pancreatic endocrine tumors,” Pathology Research and Practice, vol. 183, no. 2, pp. 155–168, 1988. View at Publisher · View at Google Scholar · View at Scopus
  10. J. S. Hill, J. T. McPhee, T. P. McDade et al., “Pancreatic neuroendocrine tumors: the impact of surgical resection on survival,” Cancer, vol. 115, no. 4, pp. 741–751, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. C. C. Solorzano, J. E. Lee, P. W. T. Pisters et al., “Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients,” Surgery, vol. 130, no. 6, pp. 1078–1085, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Q. Phan, C. J. Yeo, R. H. Hruban, K. D. Lillemoe, H. A. Pitt, and J. L. Cameron, “Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients,” Journal of Gastrointestinal Surgery, vol. 2, no. 5, pp. 473–482, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. R. T. Jenson and J. A. Norton, “Endocrine neoplasms of the pancreas,” in Textbook of Gastroenterology, T. Yamada, Ed., vol. 2, pp. 2108–2216, J. B. Lippincott, Philadelphia, Pa, USA, 2nd edition, 2003. View at Google Scholar
  14. D. Nehar, C. Lombard-Bohas, S. Olivieri et al., “Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours,” Clinical Endocrinology, vol. 60, no. 5, pp. 644–652, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Panzuto, C. Severi, R. Cannizzaro et al., “Utility of combined use of plasma levels of chromogranin A and pancreatic polypeptide in the diagnosis of gastrointestinal and pancreatic endocrine tumors,” Journal of Endocrinological Investigation, vol. 27, no. 1, pp. 6–11, 2004. View at Google Scholar · View at Scopus
  16. H. Gouya, O. Vignaux, J. Augui et al., “CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas,” The American Journal of Roentgenology, vol. 181, no. 4, pp. 987–992, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. K. K. Kazanjian, H. A. Reber, and O. J. Hines, “Resection of pancreatic neuroendocrine tumors: results of 70 cases,” Archives of Surgery, vol. 141, no. 8, pp. 765–769, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Jani, A. J. Moser, and A. Khalid, “Pancreatic Endocrine tumors,” Gastroenterology Clinics of North America, vol. 36, no. 2, pp. 431–439, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. J. A. Norton, D. T. Cromack, T. H. Shawker et al., “Intraoperative ultrasonographic localization of islet cell tumors. A prospective comparison to palpation,” Annals of Surgery, vol. 207, no. 2, pp. 160–168, 1988. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Koukouraki, L. G. Strauss, V. Georgoulias, M. Eisenhut, U. Haberkorn, and A. Dimitrakopoulou-Strauss, “Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 33, no. 10, pp. 1115–1122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Rindi, M. Falconi, C. Klersy et al., “TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study,” Journal of the National Cancer Institute, vol. 104, no. 10, pp. 764–777, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Rindi, R. Arnold, F. T. Bosman et al., “Nomenclature and classification of neuroendocrine neoplasms of the digestive system,” in WHO Classification of Tumours of the Digestive System, F. T. Bosman, F. Carniero, R. H. Hruban, and N. D. Theise, Eds., pp. 13–14, International Agency for Research on Cancer (IARC), Lyon, France, 4th edition, 2010. View at Google Scholar
  23. A. Nichols, “Simple adenoma of the pancreas arising from an island of Langerhans,” The Journal of Medical Research, vol. 8, pp. 385–395, 1902. View at Google Scholar
  24. L. E. Broder and S. K. Carter, “Pancreatic islet cell carcinoma. I. Clinical features of 52 patients,” Annals of Internal Medicine, vol. 78, no. 7, pp. 101–107, 1973. View at Google Scholar · View at Scopus
  25. P. A. Vagefi, O. Razo, V. Deshpande et al., “Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005,” Archives of Surgery, vol. 142, no. 4, pp. 347–353, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Lepage, A. M. Bouvier, J. M. Phelip, C. Hatem, C. Vernet, and J. Faivre, “Incidence and management of malignant digestive endocrine tumours in a well defined French population,” Gut, vol. 53, no. 4, pp. 549–553, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. T. L. Fitzgerald, Z. J. Hickner, M. Schmitz et al., “Increasing incidence of nonfunctional neuroendocrine tumours of the pancreas,” in Proceedings of the Gastrointestinal Cancers Symposium, Orlando, Fla, USA, 2007.
  28. J. C. Mansour and H. Chen, “Pancreatic endocrine tumors,” Journal of Surgical Research, vol. 120, no. 1, pp. 139–161, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. I. M. Modlin, E. Cornelius, G. P. Lawton, J. M. Monchik, A. L. Warshaw, and B. Kinder, “Use of an isotopic somatostatin receptor probe to image gut endocrine tumors,” Archives of Surgery, vol. 130, no. 4, pp. 367–374, 1995. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Gibril, J. C. Reynolds, J. L. Doppman et al., “Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas: a prospective study,” Annals of Internal Medicine, vol. 125, no. 1, pp. 26–34, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Gibril and R. T. Jensen, “Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours,” Digestive and Liver Disease, vol. 36, no. 1, pp. S106–S120, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Sundin, B. Eriksson, M. Bergstrom et al., “PET in the diagnosis of NE tumors,” Annals of the New York Academy of Sciences, vol. 1014, pp. 246–257, 2004. View at Publisher · View at Google Scholar
  33. R. Lebtahi, G. Cadiot, L. Sarda et al., “Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors,” Journal of Nuclear Medicine, vol. 38, no. 6, pp. 853–858, 1997. View at Google Scholar · View at Scopus
  34. E. P. Krenning, D. J. Kwekkeboom, W. H. Bakker et al., “Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients,” European Journal of Nuclear Medicine, vol. 20, no. 8, pp. 716–731, 1993. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Ricke and K. J. Klose, “Imaging procedures in neuroendocrine tumours,” Digestion, vol. 62, supplement 1, pp. 39–44, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Falconi, D. K. Bartsch, B. Eriksson et al., “ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors,” Neuroendocrinology, vol. 95, no. 2, pp. 120–134, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Shoup, P. Hodul, G. V. Aranha et al., “Defining a role for endoscopic ultrasound in staging periampullary tumors,” The American Journal of Surgery, vol. 179, no. 6, pp. 453–456, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. A. M. McLean and P. D. Fairclough, “Endoscopic ultrasound in the localisation of pancreatic islet cell tumours,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 19, no. 2, pp. 177–193, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Proye, P. Malvaux, F. Pattou et al., “Noninvasive imaging of insulinomas and gastrinomas with endoscopic ultrasonography and somatostatin receptor scintigraphy,” Surgery, vol. 124, no. 6, pp. 1134–1144, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Rosch, C. J. Lightdale, J. F. Botet et al., “Localization of pancreatic endocrine tumors by endoscopic ultrasonography,” The New England Journal of Medicine, vol. 326, no. 26, pp. 1721–1726, 1992. View at Publisher · View at Google Scholar · View at Scopus
  41. P. U. Heitz, P. Komminoth, A. Perrin et al., “Pancreatic endocrine tumors: introduction,” in Pathology and Genetics of Tumours of Endocrine Organs, D. A. DeLellis, R. V. Lloyd, P. U. Heitz, and etal, Eds., WHO Classification of Tumours, pp. 177–182, IARC Press, Lyon, France, 2004. View at Google Scholar
  42. A. Scarpa, W. Mantovani, P. Capelli et al., “Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients,” Modern Pathology, vol. 23, no. 6, pp. 824–833, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. F. Panzuto, L. Boninsegna, N. Fazio et al., “Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression,” Journal of Clinical Oncology, vol. 29, no. 17, pp. 2372–2377, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Solcia, C. Capella, and G. Kloppel, “Tumors of the pancreas,” in Atlas of Tumor Pathology, J. Rosai, Ed., pp. 215–236, Armed Forces Institute of Pathology, Washington, DC, USA, 3rd edition, 1995. View at Google Scholar
  45. “ENETS guidelines,” Neuroendocrinology, vol. 80, pp. 394–424, 2004.
  46. B. K. P. Goh, L. L. P. J. Ooi, Y. M. Tan et al., “Clinico-pathological features of cystic pancreatic endocrine neoplasms and a comparison with their solid counterparts,” European Journal of Surgical Oncology, vol. 32, no. 5, pp. 553–556, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. P. C. Buetow, T. V. Parrino, J. L. Buck et al., “Islet cell tumors of the pancreas: Pathologic-imaging correlation among size, necrosis and cysts, calcification, malignant behavior, and functional status,” American Journal of Roentgenology, vol. 165, no. 5, pp. 1175–1179, 1995. View at Publisher · View at Google Scholar · View at Scopus
  48. S. N. Hochwald, S. Zee, K. C. Conlon et al., “Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups,” Journal of Clinical Oncology, vol. 20, no. 11, pp. 2633–2642, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. M. G. House, J. L. Cameron, K. D. Lillemoe et al., “Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer,” Journal of Gastrointestinal Surgery, vol. 10, no. 1, pp. 138–145, 2006. View at Publisher · View at Google Scholar · View at Scopus